Loading clinical trials...
Loading clinical trials...
A total of 201 participants with chronic HCV GT4 infection were allocated into two groups. One group participants were treated with SOF plus RBV (24 weeks). The second group was treated with SOF plus ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Beni-Suef University
NCT01080222 · Chronic Hepatitis C Virus Infection
NCT04391985 · Chronic Hepatitis C Virus Infection
NCT04387539 · Chronic Hepatitis C Virus Infection
NCT01708889 · Chronic Hepatitis B Virus Infection, Chronic Hepatitis C Virus Infection
NCT00570336 · Chronic Hepatitis C Virus Infection
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions